Our newsletter for 2021 is out!
We are chrilled to share with you our latest newsletter.
Read about our members activites for World Scleroderma Day 2021, The very important ScleroID project which is the development of a patient reported outcome measure for systemic sclerosis, announcement of the Systemic Sclerosis World Congress which due to the ongoing COVID-19 pandemic will be virtual.
Happy reading!
news & events
2022 highlights
Watch our highlights video showing some of our great achievements in 2022.
Are you living with diffuse scleroderma?
Are you living with diffuse scleroderma?
Would you like to be involved in a clinical study testing a new investigational drug for use in Diffuse Scleroderma?
If so, you may be eligible to take part in the DECODE Scleroderma Study
This is Living!
FESCA is proud to be a partner of a the new This is Living campaign launched last month by Boehringer Ingelheim.